April 4, 2014 / 6:51 AM / 3 years ago

Meda chairman says firm has had preliminary talks with Mylan - report

1 Min Read

STOCKHOLM, April 4 (Reuters) - Swedish pharmaceutical firm Meda AB said on Friday it has had preliminary contact with generic drug maker Mylan Inc following a report in the Financial Times that the two are in talks over a deal that would create a $23 billion drug company.

"We have had preliminary contact, that is true. We are going out with a press release on that in the afternoon. More than that I cannot say," Meda chairman Bert Ake Eriksson was quoted by Swedish news agency Direkt as saying.

The exact value of the deal is unknown but Mylan is likely to pay a "significant" premium to Meda's market value, a person familiar with the matter told the Financial Times.

Meda was not immediately available for comment when contacted by Reuters. (Reporting by Mia Shanley, editing by Helena Soderpalm)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below